10-Q: Advent Technologies Faces Severe Liquidity Crisis Amidst Plummeting Revenue and Going Concern Doubts

Sentiment:

Quarterly Report


Advent Technologies Holdings, Inc. reported a drastic 95.2% decline in revenue for Q1 2025, coupled with a worsening working capital deficit and explicit substantial doubt about its ability to continue as a going concern, despite securing a significant EU grant and reducing operating expenses.

Delay expectedThe Shin-Etsu supply agreement, which provides for the purchase of bipolar plates, is currently on hold pending negotiations, potentially delaying the acquisition of critical components.The company's ability to meet its liquidity needs will largely depend on its ability to generate cash in the future, and if unable to obtain sufficient funding, it "could be required to delay its development efforts, limit activities, and further reduce research and development costs," which could adversely affect business prospects and delivery of contractual obligations.
Capital raiseThe company explicitly states that its cash and cash equivalents are "not sufficient to fund operations and capital expenditures for the twelve months following the filing of this Quarterly Report on Form 10-Q, and the Company will need to obtain additional funding in the very near term."The company plans to finance its operations and repay existing and future liabilities "through the sale of equity and/or debt securities and, to the extent available, short-term and long-term loans."On April 15, 2025, the company entered into a new term loan agreement for $870,000 with Agile Capital Funding, LLC and Agile Lending, LLC, receiving net proceeds of $443,000 after fees and repayment of a previous loan. This loan carries an extremely high effective annual interest rate of 250.67%.
Worse than expectedRevenue decreased by 95.2% from $2,738,000 in Q1 2024 to $132,000 in Q1 2025, indicating a catastrophic decline in commercial activity.The company reported a gross loss of $180,000 in Q1 2025, a significant reversal from a gross profit of $2,261,000 in Q1 2024, demonstrating a severe deterioration in profitability at the core operational level.The working capital deficit worsened to $29,096,000 as of March 31, 2025, from $26,079,000 at December 31, 2024, highlighting a deepening short-term liquidity crisis.Management explicitly concluded that "substantial doubt exists with respect to the Company’s ability to continue as a going concern for one year from the date the consolidated financial statements are issued," due to insufficient cash, recurring operating losses, and negative net working capital.The company secured a new term loan on April 15, 2025, with an extremely high effective annual interest rate of 250.67%, which is a clear indicator of severe financial distress and an inability to secure capital on reasonable terms.

Summary

  • Revenue for the three months ended March 31, 2025, plummeted to $132,000, a 95.2% decrease from $2,738,000 in the same period of 2024.
  • The company reported a gross loss of $180,000 for Q1 2025, a significant deterioration from a gross profit of $2,261,000 in Q1 2024.
  • Net loss from continuing operations improved to $3,274,000 in Q1 2025, compared to $9,416,000 in Q1 2024, primarily due to substantial reductions in administrative and selling expenses.
  • Administrative and selling expenses decreased by 63.7% to $2,250,000 in Q1 2025 from $6,193,000 in Q1 2024.
  • Research and development expenses decreased by 74.8% to $356,000 in Q1 2025 from $1,415,000 in Q1 2024.
  • Cash and cash equivalents stood at $329,000 as of March 31, 2025, down from $381,000 at December 31, 2024.
  • The company's working capital deficit worsened to $29,096,000 as of March 31, 2025, from $26,079,000 at December 31, 2024.
  • Net cash provided by operating activities from continuing operations was $282,000 in Q1 2025, a significant improvement from net cash used of $2,600,000 in Q1 2024.
  • Advent Technologies A/S, a Danish subsidiary, was declared bankrupt on July 25, 2024, leading to its liquidation and no anticipated residual assets for the company.
  • An arbitration award of approximately €4.5 million was decided against the company in favor of F.E.R. fischer Edelstahlrohre GmbH on August 16, 2024, which the company has appealed.
  • The company entered into a new term loan agreement on April 15, 2025, for $870,000, receiving net proceeds of $443,000 after fees and repayment of a previous loan, with an effective annual interest rate of 250.67%.
  • Substantial doubt exists regarding the company's ability to continue as a going concern for the next twelve months due to insufficient cash, recurring operating losses, and a negative net working capital position.
  • The company identified material weaknesses in its internal control over financial reporting related to entity-level control environment, financial statement close and reporting process, and IT processes.

Sentiment

Score: 1

Explanation: The company is in severe financial distress, evidenced by a drastic revenue decline, worsening working capital deficit, explicit going concern warning, and reliance on extremely high-interest debt. While cost reductions and a grant are noted, they are overshadowed by the immediate liquidity crisis and operational challenges.

Positives

  • Secured a €34,534,318 non-dilutive grant from the EU Innovation Fund for the RHyno Project, aimed at developing and manufacturing innovative fuel cells and electrolyzers at a megawatt scale.
  • Kicked off Phase Two of a multi-million-dollar joint benchmarking project with Airbus on February 19, 2025, to accelerate the development of Advent's Ion Pair MEA technology for aviation.
  • Continued collaboration with the U.S. Department of Defense (DoD) on the Honey Badger 50 (HB50) portable fuel cell system, including a $2.2 million contract in September 2023 for optimization and a $2.8 million contract in December 2023 for advanced manufacturing processes.
  • Achieved significant cost reductions, with administrative and selling expenses decreasing by 63.7% and research and development expenses decreasing by 74.8% year-over-year.
  • Net cash provided by operating activities from continuing operations improved significantly to $282,000 in Q1 2025, compared to a net cash outflow of $2,600,000 in Q1 2024.
  • Successfully addressed Nasdaq's minimum bid price requirement through a 1-for-30 reverse stock split effective May 13, 2024, and resolved periodic reporting delinquencies by filing overdue reports.

Negatives

  • Revenue decreased by 95.2% from $2,738,000 in Q1 2024 to $132,000 in Q1 2025, indicating a severe decline in sales.
  • Reported a gross loss of $180,000 in Q1 2025, a significant reversal from a gross profit of $2,261,000 in Q1 2024.
  • Income from grants decreased by 95.0% from $838,000 in Q1 2024 to $42,000 in Q1 2025.
  • The company's cash and cash equivalents balance is critically low at $329,000 as of March 31, 2025.
  • Working capital deficit worsened to $29,096,000 as of March 31, 2025, from $26,079,000 at December 31, 2024, indicating severe short-term liquidity issues.
  • Substantial doubt exists about the company's ability to continue as a going concern for the next twelve months.
  • Advent Technologies A/S, a Danish subsidiary, was declared bankrupt on July 25, 2024, resulting in its liquidation and no expected residual assets.
  • An arbitration award of approximately €4.5 million was decided against the company on August 16, 2024, which remains a significant financial liability despite an appeal.
  • Entered into a new term loan agreement on April 15, 2025, with an extremely high effective annual interest rate of 250.67%, highlighting the company's distressed financial state and high cost of capital.
  • Identified material weaknesses in internal control over financial reporting across multiple areas, raising concerns about financial reporting reliability.
  • Salary payments to officers have not been received since May 2024, indicating internal financial strain.

Risks

  • Ability to maintain Nasdaq listing due to ongoing compliance requirements, including stockholders' equity minimums.
  • Ability to raise sufficient future financing to fund operations and repay existing liabilities, as current cash is insufficient.
  • Success in retaining or recruiting officers, key employees, or directors, especially given financial challenges and unpaid salaries.
  • Ability to control operational costs effectively amidst scaling up production.
  • Ability to grow and manage growth profitably, given the current significant revenue decline and losses.
  • Reliance on complex machinery for operations and production, which could face disruptions.
  • Market willingness to adopt the company's technology, which is crucial for future revenue generation.
  • Ability to maintain relationships with customers, particularly major organizations with whom commercial sales have not yet materialized.
  • Potential impact of product recalls, though none are currently disclosed.
  • Ability to compete effectively within the industry, which is competitive and rapidly changing.
  • Increases in costs, disruption of supply, or shortage of raw materials.
  • Risks associated with strategic alliances or acquisitions.
  • Impact of unfavorable changes in U.S. and international regulations.
  • Availability of and ability to meet terms and conditions for government grants and economic incentives.
  • Ability to protect intellectual property rights.
  • Market conditions and global and economic factors beyond the company's control.
  • Volatility of stock price and potential share dilution from future financing activities.
  • Future exchange and interest rate fluctuations, particularly given exposure to Euros and high-interest debt.
  • Potential legal actions from creditors or employees due to overdue obligations, which could lead to liquidation.
  • Uncertainty regarding the outcome of the arbitration with F.E.R. fischer Edelstahlrohre GmbH and the former employee litigation.
  • Failure to successfully implement remediation plans for identified material weaknesses in internal controls, which could lead to material misstatements in financial statements.

Future Outlook

The company's future success is highly dependent on its ability to secure additional funding in the very near term to continue operations and meet obligations. It anticipates substantial increased demand for its fuel cell systems and MEAs as it scales up production and as its MEA capabilities become widely known. The successful development of the Advanced MEA technology, which is expected to deliver three times the power output of its current product, is a critical factor in achieving cost-competitive performance. The company expects revenues to increase materially, weighted towards Joint Development Agreements (JDAs) and Technology Assessment Agreements (TAAs) over time, and anticipates continued eligibility for grant funding. Management is committed to remediating identified material weaknesses in internal controls to enhance financial reporting reliability.

Management Comments

  • "The Company considers that the going concern basis is appropriate for the preparation of its unaudited condensed consolidated financial statements, as it is pursuing additional fund raising as disclosed below and has no intentions to proceed with liquidation."
  • "Based on the Company’s current operating plan, the Company believes that its cash and cash equivalents as of March 31, 2025, of $0.3 million is not sufficient to fund operations and capital expenditures for the twelve months following the filing of this Quarterly Report on Form 10-Q, and the Company will need to obtain additional funding in the very near term, otherwise the Company may immediately substantially curtail or terminate its operations."
  • "Because of the uncertainty in securing additional funding, delays in growth of revenue, failure to materialize cost-cutting efforts and the insufficient amount of cash and cash equivalents as of the consolidated financial statement filing date, management has concluded that substantial doubt exists with respect to the Company’s ability to continue as a going concern for one year from the date the consolidated financial statements are issued."
  • "Advent believes that its performance and future success depend on several factors that present significant opportunities for Advent but also pose risks and challenges."
  • "Advent anticipates substantial increased demand for its fuel cell systems and MEAs from a wide range of customers as it scales up its production facilities and testing capabilities, and as the awareness of its MEA capabilities becomes widely known in the industry."
  • "Advent expects both its existing customers to increase order volume, and to generate substantial new orders from major organizations, with some of whom it is already in discussions regarding prospective commercial partnerships and joint development agreements."
  • "Advent expects to play an important enabling role in the adoption of hydrogen fuel cells, as its MEA technology is the critical determining factor in the cost/kw performance ratio of the fuel cells."
  • "The successful development of the Advanced MEA will be an important factor in delivering the required improvement in cost/kw performance to Advent’s customers."
  • "Management are committed to successfully implementing the remediation plan as promptly as possible."

Industry Context

Advent Technologies operates in the rapidly evolving fuel cell and hydrogen technology space, a critical sector for global decarbonization efforts, particularly in aviation, maritime, and heavy-duty automotive industries. The company's focus on Membrane Electrode Assemblies (MEAs) positions it as a key enabler for the broader adoption of hydrogen fuel cells, as MEA performance is a determining factor in cost-effectiveness. The significant EU Innovation Fund grant for the RHyno Project underscores the European Union's commitment to hydrogen infrastructure and advanced materials, aligning Advent with major governmental clean energy initiatives. Collaborations with industry leaders like Airbus highlight the increasing interest in high-temperature fuel cell technology for challenging applications like aviation, where thermal management is crucial. The continued contracts with the U.S. Department of Defense for portable fuel cell systems demonstrate ongoing demand for advanced, lightweight power solutions in specialized defense applications. However, the industry remains competitive, and the transition to widespread commercial adoption requires substantial improvements in cost-effectiveness and scalability, which Advent aims to address with its next-generation MEA technology.

Comparison to Industry Standards

  • The company's reported revenue of $132,000 for Q1 2025 is extremely low for a publicly traded company in the advanced materials and technology development space, especially when compared to established players or even well-funded startups in the hydrogen and fuel cell sector. For instance, Plug Power (PLUG) reported Q1 2024 revenue of $120.3 million, and Ballard Power Systems (BLDP) reported Q1 2024 revenue of $14.7 million, highlighting Advent's minimal commercial sales traction.
  • The gross loss of $180,000 indicates that the company is selling its products below the cost of production or has very low sales volume, which is significantly worse than industry peers who typically aim for positive gross margins, even in early growth stages. For example, while many fuel cell companies are not yet profitable, they often demonstrate positive gross margins on product sales.
  • The negative working capital of $29.1 million and the explicit 'going concern' warning are severe indicators of financial distress, placing Advent significantly below industry standards for financial stability and liquidity. Most publicly traded companies, even those in high-growth, capital-intensive sectors, strive to maintain positive working capital or at least have clear, secured funding pathways to avoid such warnings.
  • The effective interest rate of 250.67% on the new term loan is exceptionally high and far exceeds typical commercial lending rates, even for high-risk ventures. This rate is indicative of a company in extreme financial distress, unable to secure more favorable financing, and is not comparable to standard debt financing obtained by healthier industry participants.
  • While the €34.5 million EU grant is a positive development, it is a project-specific, non-dilutive funding, and its impact on immediate operational liquidity and overall financial health needs to be balanced against the company's substantial and recurring operating losses and negative equity. Larger, more established companies like Siemens Energy or Cummins (which has a fuel cell division) secure grants and investments that are typically a smaller proportion of their overall funding needs and are not accompanied by going concern warnings.
  • The identified material weaknesses in internal control over financial reporting are a significant governance concern, placing Advent below the standards expected of publicly traded companies, which are mandated to maintain effective internal controls under Sarbanes-Oxley Act Section 404. This contrasts sharply with the robust control environments expected from industry leaders.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Interim Chief Financial OfficerN/AGary HermanN/AGary Herman is currently serving as Interim Chief Financial Officer in addition to his role as Chief Executive Officer.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessesIdentified material weaknesses in the entity-level control environment, financial statement close and reporting process, and IT processes, indicating deficiencies in internal control over financial reporting.As of March 31, 2025These weaknesses could result in a reasonable possibility of material misstatement of annual or interim financial statements not being prevented or detected on a timely basis. Management has concluded disclosure controls and procedures were not effective.
Remediation PlanCommenced remediation efforts to enhance the control environment, including hiring knowledgeable IT, accounting, and finance professionals; enhancing IT systems; improving policies and process documentation; training process owners; and increasing the frequency and independence of control testing.Ongoing, following March 31, 2025Aims to improve the reliability of financial reporting and address the identified material weaknesses, though success is not guaranteed and will take time.

Legal Proceedings

  • Litigation with former employee Chris Kaskavelis: A claim was filed on May 9, 2025, against Advent SA for €107,194.90 (unpaid wages), €612,206.40 (unpaid severance), €50,000 (moral damages), and related court expenses. The company denies the claims but has accrued $124,000 for unpaid wages. A hearing is scheduled for October 20, 2025.
  • Arbitration with F.E.R. fischer Edelstahlrohre GmbH: An arbitration decision and award of approximately €4.5 million was decided in favor of F.E.R. on August 16, 2024. The company has appealed the decision and is in settlement discussions, but the outcome is uncertain.
  • Shareholder Demand Letter and Putative Class Action: A shareholder demand to inspect books and records was made on September 14, 2023, to investigate alleged breaches of fiduciary duty by AMCI Acquisition Corp.'s board and officers related to the 2021 merger. A putative class action complaint was filed on June 5, 2024, against former AMCI officers and directors (the company is not named as a defendant).

Related Party Transactions

  • Due from related parties: As of March 31, 2025, Gary Herman (executive) owed $7,000 related to a travel expense advance.
  • Due to related parties: As of March 31, 2025, the company owed Vassilios Gregoriou $129,000, Gary Herman $40,000, and Emory S. De Castro $211,000. These balances primarily relate to short-term promissory notes due by August 31, 2026, bearing interest at 5.00% per annum. Emory S. De Castro's balance also includes $79,000 for expenses paid on behalf of the company.
  • Salary payable to officers: Other short-term payables of $1,438,000 largely consist of salary payable to the company's officers who have not received a salary payment since May 2024.

Stakeholder Impact

  • Shareholders: Face significant dilution risk from potential future equity raises, substantial share price volatility, and the risk of complete loss of investment due to the explicit going concern doubt and negative equity position. The 1-for-30 reverse stock split aimed to maintain Nasdaq listing but does not address underlying financial issues.
  • Employees: Experience uncertainty due to the company's financial distress, including unpaid salaries to officers since May 2024, and the bankruptcy of a subsidiary (Advent Technologies A/S) leading to liquidation, which could impact job security and morale.
  • Customers: May face risks related to the company's ability to deliver on contractual obligations, particularly if funding is not secured, potentially leading to delays or curtailment of development efforts and product delivery.
  • Suppliers: Face increased credit risk due to the company's negative working capital and overdue obligations, as evidenced by the bankruptcy of a subsidiary due to an unpaid claim.
  • Creditors: Are at high risk, as the company is overdue on a number of obligations, which could trigger legal action and potential liquidation. The high-interest rate on the new loan indicates the company's desperate need for capital and the perceived high risk by lenders.
  • Regulatory Authorities (Nasdaq, SEC): The company has faced and addressed multiple non-compliance issues related to listing requirements and periodic reporting, indicating ongoing scrutiny and potential for further regulatory actions if compliance is not maintained.

Next Steps

  • Obtain additional funding in the very near term to continue operations and meet liquidity needs.
  • Continue to work with the US DoD to advance the HB50 technology.
  • Finalize a settlement agreement with F.E.R. fischer Edelstahlrohre GmbH regarding the €4.5 million arbitration award, or continue the appeal process.
  • Defend against the claim filed by former employee Chris Kaskavelis, with a hearing scheduled for October 20, 2025.
  • Implement remediation efforts to address identified material weaknesses in internal control over financial reporting, including hiring professionals, enhancing IT systems, improving policies, and increasing testing.
  • Continue negotiations with Shin-Etsu Polymer Singapore Pte, Ltd regarding the supply agreement for bipolar plates.
  • Return 473 sqm of membrane stored at BASF and 4,000 sqm from Patras, Greece to BASF by December 15, 2025, as per the terminated supply agreement.
  • Pay unpaid license fees of €44,759 to BASF by April 30, 2025.

Key Dates

DateDescription
2020-08-31Company entered into a Cooperative Research and Development Agreement (CRADA) with Triad National Security, LLC, Alliance for Sustainable Energy LLC, and Brookhaven Science Associates.
2021-02-04Closing Date of the Business Combination between AMCI Acquisition Corp. and Legacy Advent, with AMCI changing its name to Advent Technologies Holdings, Inc.
2021-06-25Company entered into a Share Purchase Agreement to acquire SerEnergy A/S and fischer eco solutions GmbH.
2021-08-31Acquisition of SerEnergy A/S and fischer eco solutions GmbH completed, renamed Advent Technologies A/S and Advent Technologies GmbH.
2022-05-25Advent Technologies S.A. and UNI.FUND Mutual Fund entered into an agreement to finance Cyrus SA with a convertible bond loan of €1.0 million.
2022-08-04Launch of the Honey Badger 50 (HB50) power system and fulfillment of the first shipment order from the U.S. Department of Defense.
2022-12-01Term of the Cooperative Research and Development Agreement (CRADA) extended until March 3, 2024.
2023-06-02Company entered into an At The Market Offering Agreement (ATM Agreement) with H.C. Wainwright & Co., LLC to sell up to $50 million of common stock.
2023-09-14A purported shareholder made a demand to inspect the company's books and records to investigate alleged breaches of fiduciary duty.
2023-09-01Secured a new $2.2 million contract with the US DoD to optimize the Honey Badger 50 portable fuel cell system.
2023-11-06Advent announced an agreement with Airbus for a joint benchmarking project regarding an optimized Ion Pair Membrane Electrode Assembly (MEA).
2023-12-01Secured a new $2.8 million contract with the US DoD to develop advanced manufacturing processes for the HB50 system.
2024-01-01Term of the Cooperative Research and Development Agreement (CRADA) extended until September 3, 2024.
2024-02-02Start of period through March 28, 2024, during which 24,976 shares of common stock were issued under the At the Market Offering.
2024-04-17Received a letter from Nasdaq notifying non-compliance with periodic reporting requirements for the Annual Report on Form 10-K due March 31, 2024.
2024-04-29Stockholders approved a 1-for-30 reverse stock split of Common Stock.
2024-04-30Board approved a 1-for-30 reverse stock split of Common Stock.
2024-05-13Effective Date of the Reverse Stock Split with the Secretary of the Commonwealth of Massachusetts.
2024-05-14Common Stock began trading on a split-adjusted basis on the Nasdaq Capital Market.
2024-05-24Received a letter from Nasdaq notifying non-compliance with the minimum bid price requirement ($1.00 per share).
2024-05-24Received a letter from Nasdaq notifying non-compliance with periodic reporting requirements for the Quarterly Report on Form 10-Q for Q1 2024.
2024-05-24Purported shareholder entered into a tolling agreement with the company and former directors of AMCI, tolling claims from January 29, 2024, through June 30, 2024.
2024-06-05Purported shareholder filed a putative class action complaint against former officers and directors of AMCI.
2024-06-06Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC.
2024-06-01Company closed its facilities in Boston, Massachusetts.
2024-07-12Company formally requested to terminate the supply contract with BASF New Business GmbH.
2024-07-25Advent Technologies A/S was declared bankrupt by the court in Aalborg, Denmark.
2024-08-13Company filed its Annual Report on Form 10-K.
2024-08-16Company was informed of an arbitration decision and award in favor of F.E.R. fischer Edelstahlrohre GmbH for approximately €4.5 million.
2024-10-15Company filed its First Quarter 10-Q.
2024-10-18Received a letter from Nasdaq notifying non-compliance with the minimum stockholders' equity requirement ($2,500,000).
2024-11-05Company entered into a term loan agreement with Agile Capital Funding, LLC as collateral agent and Agile Lending, LLC as Lead Lender, borrowing $594,000.
2024-11-22Received a letter from Nasdaq notifying non-compliance with periodic reporting requirements for the Quarterly Report on Form 10-Q for Q3 2024.
2024-12-27Company filed its Third Quarter 10-Q.
2025-02-01Parties met to discuss the possibility of a settlement framework for the arbitration with F.E.R. fischer Edelstahlrohre GmbH.
2025-02-19Advent and Airbus representatives met in Hamburg, Germany to kickoff Phase Two of the joint benchmarking project.
2025-03-05European Climate, Infrastructure and Environment Executive Agency (CINEA) and Advent's Greek subsidiary signed the grant agreement for the RHyno Project.
2025-03-11Company and BASF New Business GmbH agreed to terminate the supply agreement.
2025-04-14Company issued 33,778 common shares related to the vesting of restricted stock units.
2025-04-15Company entered into a new term loan agreement with Agile Capital Funding, LLC for $870,000.
2025-04-15Company confirmed to Nasdaq its belief that it satisfied the Nasdaq continued listing requirements as its stockholders' equity exceeded the $2.5 million minimum requirement.
2025-05-09Chris Kaskavelis, a former employee, filed a claim against Advent SA before the Athens First Instance Court.
2025-06-19Maturity date for the $594,000 term loan agreement entered into on November 5, 2024.
2025-06-27Number of common stock shares issued and outstanding was 2,670,286.
2025-08-31Maturity date for short-term promissory notes with company executives and officers.
2025-09-03Extended term of the Cooperative Research and Development Agreement (CRADA) ends.
2025-09-30Extended Shin-Etsu supply agreement ends, after which Shin-Etsu can claim remaining purchase requirement.
2025-10-20Hearing scheduled for the claim filed by former employee Chris Kaskavelis.
2025-12-15Deadline for the company to return 473 sqm and 4,000 sqm of membrane to BASF.
2025-12-18Maturity date for the $870,000 term loan agreement entered into on April 15, 2025.

Recommendation

strong sell

Keywords

Fuel Cell, Hydrogen Technology, Membrane Electrode Assembly, MEA, Electrolyzers, Clean Energy, Renewable Hydrogen, Portable Power, Stationary Power, Automotive, Aviation, Energy Storage, Nasdaq Listing, Going Concern, Liquidity, SEC Filing, 10-Q, Financial Reporting, Corporate Governance, Risk Management, EU Innovation Fund, Airbus, US Department of Defense, HB50, Ion Pair MEA, Arbitration, Bankruptcy, Internal Controls, Capital Raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.